Cargando…

Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma

OBJECTIVE: We aimed to identify the minimum tumor-free margin distance conferring long-term oncological safety in patients diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage IB/II vulvar squamous cell carcinoma (VSCC). METHODS: This was a retrospective cohort study in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Micheletti, Leonardo, Preti, Mario, Cintolesi, Viviana, Corvetto, Elisabetta, Privitera, Silvana, Palmese, Eleonora, Benedetto, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078886/ https://www.ncbi.nlm.nih.gov/pubmed/30022627 http://dx.doi.org/10.3802/jgo.2018.29.e61

Ejemplares similares

Risk factors for unrecognized invasive carcinoma in patients with vulvar high-grade squamous intraepithelial lesion at vulvoscopy-directed biopsy
por: Preti, Mario, et al.
Publicado: (2017)

Four-decade trends in lymph node status of patients with vulvar squamous cell carcinoma in northern Italy
por: Preti, Mario, et al.
Publicado: (2021)

Perineural Invasion in Vulvar Squamous-Cell Carcinoma Is an Independent Risk Factor for Cancer-Specific Survival, but Not for Locoregional Recurrence: Results from a Single Tertiary Referral Center
por: Micheletti, Leonardo, et al.
Publicado: (2021)

Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center
por: Preti, Mario, et al.
Publicado: (2021)

Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women
por: Preti, Mario, et al.
Publicado: (2020)

The Prognostic Impact of Grading in FIGO IB and IIB Squamous Cell Cervical Carcinomas
por: Brambs, Christine E., et al.
Publicado: (2019)

Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging
por: Virarkar, Mayur, et al.
Publicado: (2022)

Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer
por: Sznurkowski, Jacek J., et al.
Publicado: (2012)

Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review
por: Borella, Fulvio, et al.
Publicado: (2020)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

Prognostic Significance of DNA Cytometry in Carcinoma of the Uterine Cervix FIGO Stage IB and II
por: Grote, Hans Jürgen, et al.
Publicado: (2001)

Identifying selection criteria for non‐radical hysterectomy in FIGO stage IB cervical cancer
por: Kasamatsu, Takahiro, et al.
Publicado: (2019)

MRI in the Evaluation of Locally Advanced Vulvar Cancer Treated with Chemoradiotherapy and Vulvar Cancer Recurrence: The 2021 Revision of FIGO Classification and the Need for Multidisciplinary Management
por: Miccò, Maura, et al.
Publicado: (2022)

The Role of Photodynamic Therapy in the Treatment of Vulvar Intraepithelial Neoplasia
por: Tosti, Giulio, et al.
Publicado: (2018)

The Prognostic Role of the Surgical Margins in Squamous Vulvar Cancer: A Retrospective Australian Study
por: Barlow, Ellen L., et al.
Publicado: (2020)

T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer
por: Burandt, Eike, et al.
Publicado: (2022)

Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy
por: Kong, Tae-Wook, et al.
Publicado: (2014)

Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer
por: Xu, Mu, et al.
Publicado: (2022)

Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study
por: Zhang, Hao, et al.
Publicado: (2022)

Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation
por: Heller, Debra S., et al.
Publicado: (2020)

Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022)

Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2019)

Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage
por: Balaya, Vincent, et al.
Publicado: (2020)

Vulvar Cancer: Facing a Rare Disease
por: Preti, Mario, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review
por: Buda, Alessandro, et al.
Publicado: (2022)

Impact of examined lymph node number on lymph node status and prognosis in FIGO stage IB-IIA cervical squamous cell carcinoma: A population-based study
por: Yong, Jiahui, et al.
Publicado: (2022)

Laparoscopic Transperitoneal Infrarenal Para-Aortic Lymphadenectomy in Patients with FIGO Stage IB1-II B Cervical Carcinoma
por: Hong, Dae G., et al.
Publicado: (2012)

Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer
por: Ding, Yan, et al.
Publicado: (2022)

Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer
por: Kortekaas, Kim E., et al.
Publicado: (2020)

Cellulitis and bacteraemia caused by Streptococcus dysgalactiae post radical vulvectomy and bilateral inguinal lymph node dissection for FIGO IB squamous cell carcinoma of the vulva, a case report
por: Floyd, R., et al.
Publicado: (2022)

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
por: Cetina, Lucely, et al.
Publicado: (2007)

The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2020)

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery
por: Zhang, Xiaojing, et al.
Publicado: (2020)

Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study
por: Buderath, Paul, et al.
Publicado: (2021)

Association between Three Therapeutic Strategies and Clinical Outcomes of 2009 FIGO Stage IB2/IIA2 Cervical Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Vulvar intraepithelial neoplasia: Incidence and long‐term risk of vulvar squamous cell carcinoma
por: Thuijs, Nikki B., et al.
Publicado: (2020)

The Vulvar Immunohistochemical Panel (VIP) Project: Molecular Profiles of Vulvar Squamous Cell Carcinoma
por: Garganese, Giorgia, et al.
Publicado: (2021)

Nuclear factor IB is downregulated in vulvar squamous cell carcinoma (VSCC): Unravelling differentially expressed genes in VSCC through gene expression dataset analysis
por: Dasgupta, Shatavisha, et al.
Publicado: (2021)

Early invasive vulvar squamous cell carcinoma arising in a woman with vulvar pemphigus vulgaris and systemic lupus erythematosus
por: Bifulco, Giuseppe, et al.
Publicado: (2010)

Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors
por: Fujiwara, Masateru, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_95crngrrvv8pnln81uco2fmq6o